Sunday, 21 October 2018

Case Study- Pyridostigmine Use in Myasthenia Gravis




Pyridostimine is less powerful and slower in action than neostigmine but it has longer duration of action. It has mild gastrointestinal side effects, but antimuscarinic drug is still required for stomach cramps. The total daily dose of 450 mg should not be exceeded as it leads to acetylcholine receptor downregulation. Immunosuppressant therapy is required at a daily dose of 360 mg. it is only available as a tablet, unlike neostigmine which is available as a tablet and an injection.

No comments:

Post a Comment